Study Overview
This study examines how intravenous tirofiban and the number of retrieval attempts relate to symptomatic intracranial hemorrhage (sICH) in patients undergoing endovascular therapy (EVT).
Key Findings
- Participants: 866 patients were analyzed.
- Tirofiban Use: Patients receiving tirofiban had a higher risk of sICH (OR: 1.853).
- Retrieval Attempts: More than 2 retrieval attempts significantly increased the risk of sICH (3 attempts vs. 0-1: OR: 2.482).
- Interaction Effect: The risk of sICH was notably higher in patients with multiple retrieval attempts when tirofiban was used (OR: 5.534).
Conclusion
In patients with multiple retrieval attempts, using intravenous tirofiban may raise the risk of sICH. More research is needed to tailor the use of tirofiban in EVT based on individual patient needs and procedural details.
Clinical Implications
Clinical trials are essential for developing safe treatments. To integrate these findings into practice, our AI-driven platform, DocSym, provides:
- Consolidated Knowledge: Access to ICD-11 standards, clinical protocols, and research in one place.
- Streamlined Operations: Mobile apps for scheduling, treatment monitoring, and telemedicine.
- Improved Workflows: AI tools that enhance clinic operations and patient outcomes while reducing paperwork.
Discover how we can assist you at aidevmd.com.
